The Centers for Medicare and Medicaid Services has increased the Medicare payment rate for administering monoclonal antibodies to treat beneficiaries with COVID-19, continuing coverage under the Medicare Part B COVID-19 vaccine benefit. Beneficiaries pay nothing out of pocket, regardless of where the service is furnished, whether that be at a physician’s office, healthcare facility or at home.
CMS increases Medicare payment for COVID-19 monoclonal antibody infusions
